Literature DB >> 9774771

Anti-hyperactivity medication: methylphenidate and amphetamine.

P Seeman1, B K Madras.   

Abstract

How do 'stimulants' reduce hyperactivity in children and adults? How can drugs which raise extracellular dopamine result in psychomotor slowing of hyperactive children when dopamine is known to enhance motor activity, such as in Parkinson's disease? These apparent paradoxes are the focus of this brief review on the mechanism of action of stimulant medications used in the treatment of children, and of an increasing number of adults who meet diagnostic criteria for attention deficit hyperactivity disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774771     DOI: 10.1038/sj.mp.4000421

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  54 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors.

Authors:  Glenn D Andrews; Antonieta Lavin
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

Review 3.  Biological and social influences on cognitive control processes dependent on prefrontal cortex.

Authors:  Adele Diamond
Journal:  Prog Brain Res       Date:  2011       Impact factor: 2.453

Review 4.  Animal models to guide clinical drug development in ADHD: lost in translation?

Authors:  Jeffery R Wickens; Brian I Hyland; Gail Tripp
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 5.  Using Ca2+-channel biosensors to profile amphetamines and cathinones at monoamine transporters: electro-engineering cells to detect potential new psychoactive substances.

Authors:  Tyler W E Steele; Jose M Eltit
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

6.  Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise.

Authors:  Tomas Palomo; Richard J Beninger; Richard M Kostrzewa; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

7.  Effects of methylphenidate on the aggressive behavior, serotonin and dopamine levels, and dopamine-related gene transcription in brain of male Nile tilapia (Oreochromis niloticus).

Authors:  Isabela Gertrudes Batalhão; Daína Lima; Ana Paula Montedor Russi; Camila Nomura Pereira Boscolo; Danilo Grunig Humberto Silva; Thiago Scremin Boscolo Pereira; Afonso Celso Dias Bainy; Eduardo Alves de Almeida
Journal:  Fish Physiol Biochem       Date:  2019-05-03       Impact factor: 2.794

Review 8.  Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.

Authors:  David Linton; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

9.  Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter.

Authors:  Ali Salahpour; Amy J Ramsey; Ivan O Medvedev; Brian Kile; Tatyana D Sotnikova; Ericka Holmstrand; Valentina Ghisi; Peter J Nicholls; Ling Wong; Karen Murphy; Susan R Sesack; R Mark Wightman; Raul R Gainetdinov; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

10.  Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.

Authors:  Veronika Engert; Jens C Pruessner
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.